Table 1.
Characteristics of COVID-19 Patients with Mucorales-positive PCR in respiratory samples.
| Patient | Period | Age | Sex | SARS-CoV-2 Variant | Underling Conditions | Dexamethasone | Tocilizumab | Serum M/R PCR | CAM Therapy | Aspergillus Associated | Death |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | October 2020 | 83 | m | Undetermined | Hypertension | Yes | No | Positive | L-AmB | Yes | Yes |
| B | August 2021 | 72 | m | Delta | No | Yes | Yes | Positive | L-AmB, PCZ | Yes | Yes |
| C | August 2021 | 58 | f | Delta | BMI > 30, ET | Yes | Yes | Positive | L-AmB, IVZ, PCZ | Yes | No |
| D | August 2021 | 68 | m | Delta | Hypertension, CRI | Yes | Yes | Negative | L-AmB | Yes | Yes |
| E | August 2021 | 39 | f | Delta | BMI > 30 | Yes | Yes | Negative | L-AmB, IVZ | No | No |
| F | August 2021 | 73 | m | Undetermined | Hypertension | Yes | Yes | Negative | L-AmB, IVZ | Yes | No |
| G | August 2021 | 52 | m | Delta | BMI > 30, hypertension | Yes | Yes | Negative | L-AmB, IVZ | Yes | No |
| H | August 2021 | 77 | m | Delta | DM, hypertension | No | No | Negative | No | No | Yes |
| I | August 2021 | 70 | m | Undetermined | DM, hypertension | Yes | No | Negative | L-AmB | Yes | Yes |
| J | September 2021 | 61 | m | Delta | No | Yes | Yes | Negative | IVZ | Yes | No |
ICU: intensive care unit; m: male; f: female; BMI: body mass index; CRI: chronic renal insufficiency; DM: diabetes mellitus; ET: essential thrombocytemia; M/R: Mucor/Rhizopus; CAM: COVID-19-Associated Mucormycosis; IVZ: isavuconazole; L-AmB: liposomal-amphotericin B; PCZ: posaconazole.